Armistice Capital »

Sonnet Biotherapeutc Hldng I shares owned by Armistice Capital

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $255k 272k 0.94

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Sonnet Biotherapeutc Hldng I

Armistice Capital
Vanguard Group
Tower Research Capital
BlackRock
Morgan Stanley

View all funds holding Sonnet Biotherapeutc Hldng I